331 related articles for article (PubMed ID: 9124997)
21. Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature.
Pott C; Dechering DG; Reinke F; Muszynski A; Zellerhoff S; Bittner A; Köbe J; Wasmer K; Schulze-Bahr E; Mönnig G; Kotthoff S; Eckardt L
Europace; 2011 Jun; 13(6):897-901. PubMed ID: 21292648
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms involved in reperfusion arrhythmias.
Verrier RL; Hagestad EL
Eur Heart J; 1986 May; 7 Suppl A():13-22. PubMed ID: 3522236
[TBL] [Abstract][Full Text] [Related]
23. Cardiac beta-adrenoreceptor activation and ventricular fibrillation under normal and ischemic conditions.
Bui-Xuan B; Aupetit JF; Freysz M; Loufoua J; Faucon G; Timour Q
Cardiovasc Res; 1996 Dec; 32(6):1056-63. PubMed ID: 9035900
[TBL] [Abstract][Full Text] [Related]
24. Reduced antiarrhythmic efficacy of verapamil in isolated rat hearts in the presence of elevated extracellular calcium.
Lieu PB; Fornari M; Ramos T; Hatcher AS; Clements-Jewery H
J Cardiovasc Pharmacol; 2011 Apr; 57(4):455-62. PubMed ID: 21283021
[TBL] [Abstract][Full Text] [Related]
25. Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ.
Timour Q; Aupetit JF; Loufoua-Moundanga J; Gerentes-Chassagne I; Kioueh I; Faucon G
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):645-51. PubMed ID: 1944606
[TBL] [Abstract][Full Text] [Related]
26. Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: role of myocyte structure and myocardial perfusion.
Vaillant F; Dehina L; Mazzadi A; Descotes J; Chevalier P; Tabib A; Bui-Xuan B; Riera C; Belhani D; Timour Q
Resuscitation; 2011 Aug; 82(8):1092-9. PubMed ID: 21561702
[TBL] [Abstract][Full Text] [Related]
27. Role of asynchronous activation of the ventricular fibres by an ectopic pacemaker in the accidents, especially fibrillation, caused by Ic antiarrhythmic drugs.
Timour Q; Aupetit JF; Loufoua-Moundanga J; Kioueh I; Omar S; Chevrel G; Faucon G
Fundam Clin Pharmacol; 1992; 6(4-5):159-67. PubMed ID: 1427561
[TBL] [Abstract][Full Text] [Related]
28. Potent antifibrillatory effect of combined blockade of calcium channels and 5-HT2 receptors with nexopamil during myocardial ischemia and reperfusion in dogs: comparison to diltiazem.
Nearing BD; Hutter JJ; Verrier RL
J Cardiovasc Pharmacol; 1996 Jun; 27(6):777-87. PubMed ID: 8761843
[TBL] [Abstract][Full Text] [Related]
29. Further investigations into the mechanism of antifibrillatory action of the specific IK1 blocker, RP58866, assessed using the rat dual coronary perfusion model.
Rees SA; Curtis MJ
J Mol Cell Cardiol; 1995 Dec; 27(12):2595-606. PubMed ID: 8825880
[TBL] [Abstract][Full Text] [Related]
30. Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study.
Vaillant F; Timour Q; Descotes J; Manati W; Belhani D; Bui-Xuan B; Tabib A; Bricca G; Chevalier P
J Cardiovasc Pharmacol; 2008 Dec; 52(6):548-54. PubMed ID: 19034029
[TBL] [Abstract][Full Text] [Related]
31. Antifibrillatory effects of BRL-32872 in anesthetized Yucatan minipigs with regional myocardial ischemia.
Gout B; Nichols AJ; Feuerstein GZ; Bril A
J Cardiovasc Pharmacol; 1995 Oct; 26(4):636-44. PubMed ID: 8569227
[TBL] [Abstract][Full Text] [Related]
32. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].
Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R
Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962
[TBL] [Abstract][Full Text] [Related]
33. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
34. Ventricular fibrillation in acute experimental myocardial ischemia: protection by magnesium sulfate.
Barros LF; Da-Luz PL; Silveira MC; Chagas AC; Pileggi F
Braz J Med Biol Res; 1988; 21(4):791-9. PubMed ID: 3240378
[TBL] [Abstract][Full Text] [Related]
35. Attenuation of the ischaemia-induced fall of electrical ventricular fibrillation threshold by a calcium antagonist, diltiazem.
Aupetit JF; Timour Q; Chevrel G; Loufoua-Moundanga J; Omar S; Faucon G
Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):509-14. PubMed ID: 8114951
[TBL] [Abstract][Full Text] [Related]
36. Delay by a calcium antagonist, amlodipine, of the onset of primary ventricular fibrillation in myocardial ischemia.
Timour Q; Bui-Xuan B; Faucon G; Aupetit JF
Cardiovasc Drugs Ther; 1996 Sep; 10(4):447-54. PubMed ID: 8924058
[TBL] [Abstract][Full Text] [Related]
37. Acute coronary artery occlusion-reperfusion arrhythmias in pigs: antiarrhythmic and antifibrillatory evaluation of verapamil, nifedipine, prenylamine and propranolol.
Bergey JL; Wendt RL; Nocella K; McCallum JD
Eur J Pharmacol; 1984 Jan; 97(1-2):95-103. PubMed ID: 6698112
[TBL] [Abstract][Full Text] [Related]
38. Frequency- and time-dependent depression of ventricular distal conduction by two novel antiarrhythmic drugs, cibenzoline and flecainide.
Lang J; Timour Q; Aupetit JF; Lancon JP; Lakhal M; Faucon G
Arch Int Pharmacodyn Ther; 1988; 293():97-108. PubMed ID: 3138954
[TBL] [Abstract][Full Text] [Related]
39. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy].
Gülker H; Thale J
Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228
[TBL] [Abstract][Full Text] [Related]
40. Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.
Aupetit JF; Timour Q; Larbre JP; Loufoua-Moundanga J; Kioueh I; Lopez M; Faucon G
Cardiovasc Drugs Ther; 1993 Apr; 7(2):217-23. PubMed ID: 8357775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
